Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy
Authors:
- Jesus DominguezJDJesus Dominguez
- Pengfei WuPWPengfei Wu
- C. Subah PackerCPC. Subah Packer
- Constance TemmCTConstance Temm
- Katherine J. KellyKKKatherine J. Kelly
- 1 September 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 293 (3) , F670-F679
Abstract
Anomalous inflammatory responses triggered by the metabolic syndrome cause renal injury. This discovery links renal lipid accumulation with lipotoxicity to inflammation and may explain the insidious fibrosis and cellular decay characteristic of nephropathy in the metabolic syndrome. However, it is not clear whether control of inflammation protects the kidney independently of lipid accumulation, which is a required step for lipotoxicity in hyperglycemia and dyslipidemia. We hypothesized that in rats with the metabolic syndrome, and overt nephropathy, treatment with mycophenolate mofetil (MMF; 10 mg·kg−1·day−1 ip for 14 wk) would reduce the abnormal renal lipid depots and limit renal inflammation and injury. We studied groups of lean and obese F1 hybrid Zucker fatty diabetic/spontaneous hypertensive heart failure (ZS) rats. MMF did not affect lean rats. In obese ZS rats, MMF did not change severe hyperglycemia or the higher kidney loads of unutilized lipid and peroxidation products. Nonetheless, MMF dramatically reduced diabetes/obesity-derived systemic and renal inflammation, limited renal size, hyperfiltration, and fibrosis. These data indicate that in rats, anti-inflammatory therapy presumably acting downstream, and independently of lipotoxicity, can effectively limit renal injury and fibrosis.Keywords
This publication has 54 references indexed in Scilit:
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- AMP-activated protein kinase signaling in metabolic regulationJournal of Clinical Investigation, 2006
- Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein ItselfCirculation Research, 2005
- Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertensionKidney International, 2005
- Mycophenolate mofetil ameliorates nephropathy in the obese Zucker ratKidney International, 2005
- Lipid Droplets Gain PAT Family Proteins by Interaction with Specialized Plasma Membrane DomainsJournal of Biological Chemistry, 2005
- Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusionKidney International, 2005
- Immunosuppression for diabetic glomerular disease?Kidney International, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Different Domains Cooperate to Target the Human Ribosomal L7a Protein to the Nucleus and to the NucleoliJournal of Biological Chemistry, 1997